Covid closures cramp Truscreen

May 30, 2022 | Latest News

30.5.22 Cervical cancer technology company Truscreen Group) has improved product sales but recorded a larger loss in its preliminary unaudited financial results for the year ended 31 March 2022. Financial Results for the year ended 31 March 2022 Truscreen generated product sales of $1.7m (2021: $1.1m) a 48% increase on the prior year with China […]

You need an active membership to keep reading

either log in via the form below or click here to subscribe

If you have recently subscribed and selected to pay by bank transfer our admin team will activate your membership once payment has cleared

[adrotate banner="4"]

Covid closures cramp Truscreen

You need an active membership to keep reading

either log in via the form below or click here to subscribe

Your Advertisement Here

Your Advertisement Here